Trials / Completed
CompletedNCT04260347
SITS-IVT in Patients >80 Years Study
Safe Implementation of Treatments in Stroke (SITS) - Intravenous Thrombolysis in Acute Ischaemic Stroke Patients Over 80 Years, SITS-IVT>80 Years Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,655 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 80 Years
- Healthy volunteers
- Not accepted
Summary
A non-interventional post-approval study on Safe Implementation of Treatment in Stroke - International Stroke Thrombolysis Register (SITS-ISTR) existing data of intravenous recombinant tissue plasminogen Activator (rt-PA) (0.9 mg/kg) in acute ischaemic stroke patients over 80 years, treated according to the Summary of Product Characteristics (SmPC) in European countries.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Alteplase | Intravenous injection |
Timeline
- Start date
- 2020-05-14
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2020-02-07
- Last updated
- 2024-07-05
- Results posted
- 2024-07-05
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT04260347. Inclusion in this directory is not an endorsement.